Response Genetics
Cancer Genetics Inc. | Empowering Personalized Cancer Treatment.
Launch date
Employees
Market cap
-
Enterprise valuation
€13m (Public information from Aug 2015)
Los Angeles California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $12.0m | Post IPO Debt | |
$14.0m Valuation: $14.0m | Acquisition | ||
Total Funding | - |